IFG Advisory’s Co-Diagnostics CODX Stock Holding History

IFG Advisory’s Portfolio CODX Stock Details CODX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-521	Closed	-$128K	–	482
2021 Q2	$128K	Sell	521 -2,492	-83%	-$641K	0.01%	465
2021 Q1	$862K	Buy	3,013 +59	+2%	+$23.6K	0.11%	214
2020 Q4	$824K	Sell	2,954 -1,821	-38%	-$675K	0.11%	197
2020 Q3	$1.95M	Buy	4,775 +2,739	+135%	+$1.41M	0.32%	71
2020 Q2	$1.18M	Hold	2,036	–	–	0.21%	114
2020 Q1	$465K	Buy	+2,036	New	+$353K	0.1%	203

Other funds holding CODX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

PPA

Parametric Portfolio Associates Seattle, Washington $190B AUM 18.52% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return

ARC

Advisor Resource Council Dallas, Texas $309M AUM 22.32% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

IFG Advisory's CODX Position: Q3 2021 in Review

IFG Advisory sold out of Co-Diagnostics (CODX) in Q3 2021, closing a stake of 521 shares — an estimated $128K sold.

IFG Advisory first reported a position in CODX in Q1 2020 and held it in 6 quarters. The position peaked at $1.95M in Q3 2020. 78 funds tracked by Wall St. Rank hold CODX as of Q3 2021.

IFG Advisory reported no remaining Co-Diagnostics position as of Q3 2021 after selling out during the quarter.
IFG Advisory sold 521 Co-Diagnostics shares in Q3 2021, an estimated $128K.
IFG Advisory first reported a position in Co-Diagnostics in Q1 2020 and held it in 6 quarters.
IFG Advisory's Co-Diagnostics position peaked at $1.95M in Q3 2020.
78 funds tracked by Wall St. Rank held Co-Diagnostics as of Q3 2021.

Based on IFG Advisory's 13F filing for Q3 2021, filed 12 Oct 2021.